The story of Theranos is not simply about how its leaders behaved, and whether they deliberately misled others. It is also about how people take decisions
Whatever the verdict in Ms Holmes’s ongoing trial, on charges of defrauding investors and patients by making false claims about the startup’s blood-testing technology, she is right about that. The story of Theranos is not simply about how its leaders behaved, and whether they deliberately misled others. It is also about how people take decisions.
Charisma is a reasonable trait for investors to like in a startup founder. But people too easily equate confidence with competence. In a study from 2012, researchers from the University of Lausanne taught a bunch of mid-level managers a set of “charismatic leadership tactics”—from three-point lists and moral conviction to hand gestures. Observers’ assessment of the managers' competence leapt as a result.
The documents themselves look risible. “All the laws of nature, all secrets, are imprinted on every cell of our body,” writes Mr Balwani, a somewhat concerning statement from the leader of a medical startup. Ms Holmes’s note includes lines such as “I know the outcome of every encounter”, “I constantly make decisions and change them as needed” and “My hands are always in my pockets or gesturing”. But the formula, if that is what it was, seems to have worked.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Elizabeth Holmes rests her case after testifying for 7 days in fraud trialThe former Theranos CEO could be sentenced to decades in prison if convicted.
Weiterlesen »
Holmes ends defense in Theranos fraud trialAfter seven days, Elizabeth Holmes was her own final witness in her defense against federal fraud charges tied to her failed blood-testing startup as testimony concluded Wednesday in the Theranos trial.
Weiterlesen »
Inside the Trial of Elizabeth Holmes - The Journal. - WSJ PodcastsToday the defense rested in the trial of Elizabeth Holmes, the former CEO of Theranos. WSJ's Sara Randazzo takes us inside the trial, from the prosecution's arguments to the moment Holmes took the stand herself.
Weiterlesen »
Elizabeth Holmes’s Lawyers Rest Their Case in Criminal-Fraud TrialAttorneys for the founder of blood-testing startup Theranos wound up their case, including several days of her testimony, in which she acknowledged regrets but also placed blame on her former deputy and boyfriend.
Weiterlesen »
Defense team rests in Elizabeth Holmes fraud trial | AP NewsThe defense has rested in the criminal fraud trial of fallen Theranos founder Elizabeth Holmes. Closing arguments are scheduled December 16-17. Holmes is accused of misleading investors and others about a flawed blood-testing technology.
Weiterlesen »